Animal Vaccination Sample Clauses

Animal Vaccination. Routine dog vaccination is a critical component of rabies prevention among dogs and humans. Figure 8 illustrates the dog vaccination coverage achieved during the vaccination campaign conducted in conjunction with this survey. Vaccinated dog numbers are based on the number of dogs brought by owners for vaccination, and unvaccinated numbers are based upon the remaining reporting household dog size. Dog Vaccination Coverage by Settlement Type 100.00% 90.00% 80.00% 70.00% 60.00% 50.00% 40.00% 30.00% 20.00% 10.00% 0.00% 95.28% 84.04% 78.57% 21.43% 15.96% 4.72% Urban Semi-Urban Type of Settlement Rural Dogs Vaccinated Dogs Not Vaccinated Percent of Respondents Figure 8: Campaign Dog Vaccination Coverage (N=1434) a a 13 missing observations and 1 observation that vaccinated more dogs than those owned not included in figure X b Vaccinated dog numbers based on those vaccinated at the time of survey c Non vaccinated numbers determined by reported household dog size Campaign coverage was most successful in urban areas, with around 95 percent of dogs owned by clinic participants vaccinated as a result of this campaign. Semi-urban areas had a high but lower coverage of 84 percent. Rural areas experienced the lowest coverage; around 78 percent of owned household dogs were vaccinated because of this campaign. While all rates exceed the established minimum coverage of 70 percent for achieving herd immunity, the proportion of household dog owners who never presented for campaign vaccination is unknown, as is the proportion of community owned and stray dogs. Therefore, the true coverage rate for these communities cannot be determined without additional studies.
Sample 1
AutoNDA by SimpleDocs
Animal Vaccination. The prevalence of canine rabies and the low provision of veterinary care among owned dogs indicate that there is a significant gap in animal rabies vaccinations. The Haitian Ministry of Agriculture conducted several sporadic mass dog vaccination campaigns in the past. Most recently in 2012, a total of 400,000 dogs were vaccinated [2]. By our estimate of an owned dog population of 1,143,750, the proportion of dogs vaccinated in 2012 was around 35%. As previously established, a vaccination threshold of 70 % is critical to achieving herd immunity. Significantly under-vaccinating a population does not successfully control the spread of rabies, particularly when there is a high population turnover and campaigns are not conducted regularly. The relatively high vaccination coverage achieved among dog-owning households within a vaccination site in our study demonstrates that motivated dog owners will vaccinate their animals when the opportunity arises and that sustained mass vaccination campaigns in Haiti are likely to achieve herd immunity among dog populations. Although the proportion of dog owners who never presented their animals for vaccination is unknown, participation in this vaccination clinic is promising. Unvaccinated dog numbers among participants could represent dogs previously vaccinated or dogs too young to vaccinate, so it is not possible to estimate true vaccination coverage among the total surveyed dog population. However, the high vaccination coverage among dog-owning households shows that most household dogs were unvaccinated prior to this campaign, suggesting that access to vaccines may be a crucial component of achieving dog vaccination among this population. Lower vaccination coverage in rural areas, as compared to urban areas, could be a result of a greater proportion of dogs that roam unsupervised and were not able to be located for vaccination. Knowledge of the campaign was also critical to owner turnout. Our campaign was announced over loudspeakers twice before the vaccination clinic was established in a central location. Similar campaigns conducted in the Philippines and Xxxx were also advertised either door-to-door, via pamphlets or posters, by word of mouth from community leaders, or over loudspeakers before implementation and achieved anywhere from 70 to 88 percent vaccination coverage of owned dogs and 64 to 87 percent of total dogs [51, 52]. This consistency with our results indicates that necessary vaccination thresholds for herd i...
Sample 1

Related to Animal Vaccination

  • Influenza Vaccination The parties agree that influenza vaccinations may be beneficial for patients and employees. Upon a recommendation pertaining to a facility or a specifically designated area(s) thereof from the Medical Officer of Health or in compliance with applicable provincial legislation, the following rules will apply:

  • Vaccinations Contractor understands, acknowledges, and agrees that, pursuant to Article II of the General Appropriations Act, none of the General Revenue Funds appropriated to the Department of State Health Services (DSHS) may be used for the purpose of promoting or advertising COVID-19 vaccinations in the 2024-25 biennium. It is also the intent of the legislature that to the extent allowed by federal law, any federal funds allocated to DSHS shall be expended for activities other than promoting or advertising COVID-19 vaccinations. Contractor represents and warrants that it is not ineligible, nor will it be ineligible during the term of this Contract, to receive appropriated funding pursuant to Article II.

  • Outpatient Dental Anesthesia Services This plan covers anesthesia services received in connection with a dental service when provided in a hospital or freestanding ambulatory surgical center and: • the use of this is medically necessary; and • the setting in which the service is received is determined to be appropriate. This plan also covers facility fees associated with these services.

  • Study Population ‌ Infants who underwent creation of an enterostomy receiving postoperative care and awaiting enterostomy closure: to be assessed for eligibility: n = 201 to be assigned to the study: n = 106 to be analysed: n = 106 Duration of intervention per patient of the intervention group: 6 weeks between enterostomy creation and enterostomy closure Follow-up per patient: 3 months, 6 months and 12 months post enterostomy closure, following enterostomy closure (12-month follow-up only applicable for patients that are recruited early enough to complete this follow-up within the 48 month of overall study duration).

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Durable Medical Equipment (DME), Medical Supplies Prosthetic Devices, Enteral Formula or Food, and Hair Prosthesis (Wigs) • Items typically found in the home that do not need a prescription and are easily obtainable such as, but not limited to: o adhesive bandages; o elastic bandages; o gauze pads; and o alcohol swabs. • DME and medical supplies prescribed primarily for the convenience of the member or the member’s family, including but not limited to, duplicate DME or medical supplies for use in multiple locations or any DME or medical supplies used primarily to assist a caregiver. • Non-wearable automatic external defibrillators. • Replacement of durable medical equipment and prosthetic devices prescribed because of a desire for new equipment or new technology. • Equipment that does not meet the basic functional need of the average person. • DME that does not directly improve the function of the member. • Medical supplies provided during an office visit. • Pillows or batteries, except when used for the operation of a covered prosthetic device, or items for which the sole function is to improve the quality of life or mental wellbeing. • Repair or replacement of DME when the equipment is under warranty, covered by the manufacturer, or during the rental period. • Infant formula, nutritional supplements and food, or food products, whether or not prescribed, unless required by R.I. Law §27-20-56 for Enteral Nutrition Products, or delivered through a feeding tube as the sole source of nutrition. • Corrective or orthopedic shoes and orthotic devices used in connection with footwear, unless for the treatment of diabetes. Experimental or Investigational Services • Treatments, procedures, facilities, equipment, drugs, devices, supplies, or services that are experimental or investigational except as described in Section 3. Gender Reassignment Services • Reversal of gender reassignment surgery.

  • Vaccination and Inoculation (a) The Employer agrees to take all reasonable precautions, including in-service seminars, to limit the spread of infectious diseases among employees.

  • Patients The Dentist shall accept Covered Persons as patients as reasonably permitted by the Dentist's patient load and appointment calendar. The Dentist will provide Covered Dental Services to Covered Persons on the same basis as to the Dentist's other patients (for example: scheduling, quality of service, and fee charges). The Dentist will be solely responsible to Covered Persons for dental advice and treatment; SDC will have no control over Dentist's practice or the dentist-patient relationship.

  • Rhytidectomy Scar revision, regardless of symptoms. • Sclerotherapy for spider veins. • Skin tag removal. • Subcutaneous injection of filling material. • Suction assisted Lipectomy. • Tattooing or tattoo removal except tattooing of the nipple/areola related to a mastectomy. • Treatment of vitiligo. • Standby services of an assistant surgeon or anesthesiologist. • Orthodontic services related to orthognathic surgery. • Cosmetic procedures when performed primarily: o to refine or reshape body structures or dental structures that are not functionally impaired; o to improve appearance or self-esteem; or o for other psychological, psychiatric or emotional reasons. • Drugs, biological products, hospital charges, pathology, radiology fees and charges for surgeons, assistant surgeons, attending physicians and any other incidental services, which are related to cosmetic surgery.

Time is Money Join Law Insider Premium to draft better contracts faster.